Does the STAT4 rs7574865 T allele increase risk for autoimmune thyroid disease by amplifying Th1/Th17 signaling?

The STAT4 gene encodes a pivotal transcription factor that mediates immune signaling. The intronic rs7574865 single nucleotide polymorphism (specifically the T risk allele) serves as a critical genetic link connecting intracellular signaling amplification to systemic and organ-specific autoimmunity.

Clinical evidence of autoimmune susceptibility

• Broad Autoimmunity: The T minor allele of rs7574865 consistently elevates the risk of systemic autoimmune diseases, demonstrating odds ratios of 1.52 to 1.56 for systemic lupus erythematosus (SLE), alongside robust associations with rheumatoid arthritis, systemic sclerosis, and primary Sjögren’s syndrome.
• Thyroid Autoimmunity: In autoimmune thyroid disease—encompassing both Graves' disease and Hashimoto's thyroiditis—individuals with the homozygous TT genotype exhibit a 1.55 to 1.63-fold increase in odds compared to those with the homozygous GG genotype, with prominent replication in European and Asian cohorts.

Mechanistic pathways of the rs7574865 variant

• Expression and Activation: The rs7574865 T allele functions as a cis-expression quantitative trait locus (eQTL) that increases baseline STAT4 mRNA and protein levels in peripheral blood mononuclear cells (PBMCs) and activated immune cells.
• Signaling Cascade: Elevated STAT4 levels amplify intracellular signaling downstream of interleukin-12 (IL-12), interleukin-23 (IL-23), and type I interferons. This prompts enhanced STAT4 phosphorylation, dimerization, and nuclear translocation.
• Th1/Th17 Differentiation: This signaling cascade drives CD4+ T cells toward pro-inflammatory Th1 and Th17 lineages, resulting in the overproduction of effector cytokines such as interferon-gamma (IFN-γ) and interleukin-17A (IL-17A) which promote tissue infiltration and chronic inflammation.

Bottom line

• The STAT4 rs7574865 risk allele significantly predisposes individuals to diverse autoimmune conditions, including a 1.5- to 1.6-fold increased risk for autoimmune thyroid disease, by functioning as a genetic driver that amplifies STAT4 expression and fuels pathogenic Th1/Th17-mediated inflammatory pathways.